An antibiotic, Tigecycline makes 74 % cure rate in cSSSI patients An antibiotic, becoming tested in clinical trials, produced a 74 % cure price for hospitalized patients with life-threatening possibly, complicated skin and pores and skin framework infections . Tigecycline, an applicant antibiotic drug, produced these promising results in a report led by Russell G. Postier, M drug .D., OU Doctors Chairman of John and Surgery treatment A. Schilling Professor of Medical procedures at the University of Oklahoma College of Medicine. ‘Tigecycline displayed promising efficacy against a wide spectrum bacteria commonly related to complicated skin infections, with an acceptable basic safety profile. These data warrant further investigation in blinded comparator scientific trials, stated Postier, John A.
Kaiser Family Foundation. Copyright 2009 Advisory Board Organization and Kaiser Family Base. All rights reserved.. An already-changing insurance marketplace may face more transformation The Wall Street Journal: Insurers are increasingly establishing brick-and-mortar shops that peddle individual and sometimes small-group health plans, with companies including Humana Inc., Aetna Inc. And Health Net Inc. Up to now trying the concept. Blue Cross Blue Shield plans in Pennsylvania and SC say they’ve had great results from shops, while Blue Cross & Blue Shield of Florida Inc. Programs to add five more locations following the success of its existing two. Of individuals under 65 who purchase their own health plans, simply 1 percent made their purchases at shops. Information differ, but the big health expenses now under consideration in both chambers would set up a nationwide program of insurance exchanges – government-run, Web-centered marketplaces designed to make it possible for consumers to compare the huge benefits and costs of obtainable insurance options.